Tuesday, June 20, 2017 3:55:38 PM
Anyways, to the people who are actual investors, I am following up on my previous. Still awaiting the investigation. Remember this...
Hi all,
Little bit of progress. I will post it all. Patent office sent me an email..Thank you for contacting the USPTO Contact Center.
For assignment inquiries, please contact the Assignment Services Branch at (571) 272-3350 between 8:30 a.m. and 5:00 p.m. Eastern Time on normal business days.
If you have any further questions or if you require additional information, please call the USPTO Contact Center at 1-800-786-9199 or (571) 272-1000 and reference the following Service Request number: 1-488477918.
I called the rep this morning....said the patent office shows Advanomics owning the patent....BUT...I mentioned the agreement between the two companies, he stated since it was a "business decisions" and if the company doesn't care about shareholder input, then as long as it's filed with the SEC (which it is), it's technically a legal agreement. Didn't get into why they still bill Advanomics for non payment.
Part 2.
I contacted the SEC today, they told me it was a "business decision", as long as it was filed correctly, the appropriate parties would review the numbers for validity/red flags. I explained the same people buying a 51K asset (patent), few years later selling it to a broke public traded company for 4million, she was shocked. She told me: I'd have to contact the state with the business was incorporate (Colorado). I sent this email:
Hi,
I am an investor of the company: Sunshine Biopharma (SBFM), they evidentally were incorporated in Colorado, but reside in another country, Canada. I spoke with the SEC about some issues I have with the company, and wanted a few items clarified.
They are run by 3 individuals, they apparently have/own ALL voting rights, so shareholders have little to no say in business decisions. Do investors have any recourse here? The reason I ask, is these same 3, own a private company in Canada, known as: Advanomics corporation. It has been shown on numerous quarterly filings, that they exchange stocks, assets, and monies back and forth, to their benefit, as they own both.
My issue is the purchase of a patent. Advanomics paid a company 51,000USD for a French patent, from a French company.....as a private company (Advanomics), they held the patent for some years, let it rot, or realized it was useless or a failed patent......then turned around and sold it to themselves for over 4million dollars, funded it with shareholder money. I understand it may be considered a "business decisions", but I'd like some accountability on how they got that number/justification for wasting our investment on a literally useless patent. All this information is filed with the SEC, I just don't understand how this could be allowed as a legitimate business decision/transaction, they are simply funneling money from a public traded company, to a private one. Using investors. Sunshine has reported yearly losses year over year, not sure they have ever made money, let alone afford a 4 million patent, on a patent that had no provable value greater than what they bought it for, 51,000USD. If it wasn't about making the private entity rich, and about "curing cancer", why not gift it, you own both companies...this is highly suspect, and needs to be reviewed!
I'd like to know if shareholders have a right here, and what we can do. If this is legal, I am going to start a private business, and a public one, and make myself a millionaire on lies and assumptions.
Feel free to call me,
Part 3
The inspector general called me 20minutes ago, came up "restricted" and all.....told me it "stunk to the high heaven with red flags", that I should call the Canadian authorities in Canada immediately as she has no jurisdiction. They didn't even have an address for this place. Wish I could play back the voice mail I got from her. Wish she could have handled it, but she did say the Canadians take this kind of stuff very seriously, it would be handled.
So when I get some time, hopefully this is the last stop to putting these guys away, or fined, whatever. There is no logical explanation to why that patent sold for what it did, to a broke company, plain and simple.
Stay Tuned....I'm coming for you Camille ;)
For those who still don't believe, I strongly recommend you review your financial decision here. How can they possibly justify the price tag on that patent?! It's a dead patent.
Recent SBFM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/20/2024 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/16/2024 09:00:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:09 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/11/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM